Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Renovaro Inc. - Common Stock (NQ:RENB)

0.2793 +0.0073 (+2.68%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Renovaro Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
RENOVARO BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Renovaro Biosciences Inc. - RENB
From Kahn Swick & Foti, LLC
Via Business Wire
New Prediction Model Could Slash Unnecessary Pancreatic Cancer Biopsies
Via Investor Brand Network
Top 5 Health Care Stocks That May Plunge In October
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. 
Via Benzinga
BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) CEO Releases Shareholder Letter Regarding Agreement to Combine with Leading AI Company
Via Investor Brand Network
Topics Artificial Intelligence
Message from Renovaro Biosciences CEO, The Hon. Mark Dybul, MD
AI Company GEDiCube and Renovaro Biosciences Sign Definitive Agreement to Combine 
From Renovaro Biosciences Inc.
Via GlobeNewswire
AI Company GEDiCube and Renovaro Biosciences Sign Definitive Agreement to Combine
From Renovaro Biosciences Inc.
Via GlobeNewswire
BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) Enters Definitive Agreement to Combine with Leading AI Tech GEDi Cube
Via Investor Brand Network
Topics Artificial Intelligence
RENB Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Renovaro Biosciences Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Renovaro Biosciences and AI Health Company GEDi Cube Sign Definitive Agreement to Combine
From Renovaro Biosciences Inc.
Via GlobeNewswire
Eliminating Barriers Surrounding Solid Tumors Allows T Cells to Kill Cancerous Cells
Via Investor Brand Network
Why Colon Cancer Is Largely Unresponsive to Immunotherapy
Via Investor Brand Network
BioMedNewsBreaks – IBN’s BioMedWire Highlights NanoVibronix Inc.’s (NASDAQ: NAOV) $5M Private Placement
Via Investor Brand Network
Renovaro BioSciences Inc. (NASDAQ: RENB) Targets Pancreatic Cancer Solution Through Work With GEDI Cube AI Platform, NVIDIA Resources
Via Investor Brand Network
Topics Artificial Intelligence
UI Research Suggests Immune System Can Be Trained to Combat Solid Tumors
Via Investor Brand Network
BioMedNewsBreaks — Why Renovaro BioSciences Inc. (NASDAQ: RENB) Is ‘One to Watch’
Via Investor Brand Network
Stack Foundation Gives UC San Diego $5M Gift to Advance Gene Therapy
Via Investor Brand Network
Tracking Off-Label Cancer Treatment Could Ease Future Trials, Remedies
Via Investor Brand Network
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time for another breakdown of the biggest pre-market stock movers as we dive into all of the latest news for Thursday! 
Via InvestorPlace
UC San Diego Researchers Suggest Stem Cell Transplantation Could Treat Alzheimer’s
Via Investor Brand Network
BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) Congratulates GEDiCube on New Joint Effort Clinical Trials
Via Investor Brand Network
Topics Artificial Intelligence
Renovaro BioSciences Welcomes GEDiCube Announcement of New Joint Effort
From Renovaro Biosciences Inc.
Via GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
We're starting off the week with a breakdown of the biggest pre-market stock movers worth reading about on Monday morning! 
Via InvestorPlace
Renovaro BioSciences Inc. (NASDAQ: RENB) Aims to Unlock Potential Treatments and Cures for Serious Infectious Diseases and Cancer
Via Investor Brand Network
Australia Brings New HIV Infections to Near Zero
Via Investor Brand Network
BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Eyes Clear Path to IND Submission for Innovative Cancer Platform
Via Investor Brand Network
Renovaro BioSciences Inc. (NASDAQ: RENB), Immunotherapy Biotech Company, Announces Intention to Unite With AI Tech Developer GEDi Cube, Seen as Major Multiplier Effect in the Fight Against Cancer
Via Investor Brand Network
Topics Artificial Intelligence
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Macy's Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) shares jumped 42.8% to $5.60 after the FDA lifted clinical hold on the company’s FTX-6058 for sickle cell disease. 
Via Benzinga
BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Congratulates GEDi Cube on Appointment of Expert in Clinical Medicine and Digital Health
Via Investor Brand Network
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.